|Title:||The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study||Authors:||Huang, Yen-Hsiang
|Keywords:||epidermal growth factor receptor; local treatment; more than five years; non-small cell lung cancer; scoring model; tyrosine kinase inhibitor||Issue Date:||2021||Journal Volume:||13||Source:||Therapeutic advances in medical oncology||Abstract:||
The relative importance of predictive factors for advanced non-small cell lung cancer (NSCLC) patients on epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment remains unclear.
epidermal growth factor receptor; erlotinib; gefitinib; protein tyrosine kinase inhibitor; accuracy; adrenal metastasis; adult; advanced cancer; aged; allele; amino acid sequence; area under the curve; Article; biopsy; bone metastasis; brain metastasis; cancer patient; cancer radiotherapy; cancer recurrence; cancer research; cancer staging; cancer surgery; chemoradiotherapy; chronic patient; cohort analysis; computer assisted tomography; confidence interval; controlled study; diagnostic test accuracy study; disease exacerbation; DNA sequence; ECOG Performance Status; exon; female; follow up; gene mutation; genetic screening; heterozygote; human; human cell; human tissue; liquid biopsy; liver metastasis; local therapy; lung cancer; lung lesion; major clinical study; male; mass spectrometry; medical history; multicenter study; non small cell lung cancer; plasma cell; postoperative complication; prediction; predictive value; prevalence; primary tumor; receiver operating characteristic; retrospective study; risk factor; scoring system; sensitivity and specificity; small cell lung cancer; smoking; stomach cancer; system analysis
|Appears in Collections:||醫學檢驗暨生物技術學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.